ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,046 filers reported holding ASTRAZENECA PLC in Q3 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,074,380 | +4.9% | 15,865 | +10.9% | 0.06% | +10.7% |
| Q2 2023 | $1,024,241 | +7.4% | 14,311 | +4.1% | 0.06% | +1.8% |
| Q1 2023 | $953,768 | +27.3% | 13,741 | +24.4% | 0.06% | +19.6% |
| Q4 2022 | $749,054 | -11.6% | 11,048 | -28.5% | 0.05% | -20.7% |
| Q3 2022 | $847,000 | -53.0% | 15,442 | -43.4% | 0.06% | -49.6% |
| Q2 2022 | $1,803,000 | -7.3% | 27,283 | -7.0% | 0.12% | +7.5% |
| Q1 2022 | $1,946,000 | +14.0% | 29,340 | +0.1% | 0.11% | +20.2% |
| Q4 2021 | $1,707,000 | -3.5% | 29,311 | -0.5% | 0.09% | -10.1% |
| Q3 2021 | $1,769,000 | -1.6% | 29,457 | -1.8% | 0.10% | -2.0% |
| Q2 2021 | $1,797,000 | +9.8% | 30,006 | -8.9% | 0.10% | +3.1% |
| Q1 2021 | $1,637,000 | -3.1% | 32,920 | -2.6% | 0.10% | -10.1% |
| Q4 2020 | $1,689,000 | -23.1% | 33,784 | -15.6% | 0.11% | -31.4% |
| Q3 2020 | $2,195,000 | -4.0% | 40,048 | -7.4% | 0.16% | -8.6% |
| Q2 2020 | $2,286,000 | -4.6% | 43,227 | -19.5% | 0.17% | -16.7% |
| Q1 2020 | $2,397,000 | -14.0% | 53,665 | -4.0% | 0.21% | +9.4% |
| Q4 2019 | $2,787,000 | +8.0% | 55,902 | -3.4% | 0.19% | 0.0% |
| Q3 2019 | $2,580,000 | +4.7% | 57,879 | -3.1% | 0.19% | +3.8% |
| Q2 2019 | $2,465,000 | -19.4% | 59,723 | -21.0% | 0.18% | -21.0% |
| Q1 2019 | $3,057,000 | -4.3% | 75,624 | -10.1% | 0.23% | -15.6% |
| Q4 2018 | $3,195,000 | -13.0% | 84,124 | -9.4% | 0.28% | -2.5% |
| Q3 2018 | $3,674,000 | +6.4% | 92,839 | -5.6% | 0.28% | -1.0% |
| Q2 2018 | $3,452,000 | +0.1% | 98,320 | -0.3% | 0.29% | -0.7% |
| Q1 2018 | $3,448,000 | +1.7% | 98,590 | +0.9% | 0.29% | +4.0% |
| Q4 2017 | $3,391,000 | +4.7% | 97,709 | +2.2% | 0.28% | +1.5% |
| Q3 2017 | $3,238,000 | -12.7% | 95,575 | -12.1% | 0.27% | -15.7% |
| Q2 2017 | $3,708,000 | +15.3% | 108,760 | +5.3% | 0.32% | +12.1% |
| Q1 2017 | $3,216,000 | +36.2% | 103,287 | +19.5% | 0.29% | +32.0% |
| Q4 2016 | $2,362,000 | +95.5% | 86,468 | +135.2% | 0.22% | +97.3% |
| Q3 2016 | $1,208,000 | +43.6% | 36,771 | +31.9% | 0.11% | +22.0% |
| Q2 2016 | $841,000 | +39.0% | 27,871 | +29.8% | 0.09% | +40.0% |
| Q1 2016 | $605,000 | +23.5% | 21,470 | +48.8% | 0.06% | +16.1% |
| Q4 2015 | $490,000 | -6.5% | 14,425 | +96.6% | 0.06% | +14.3% |
| Q3 2014 | $524,000 | -18.8% | 7,337 | -15.5% | 0.05% | -19.7% |
| Q2 2014 | $645,000 | -93.1% | 8,679 | -93.9% | 0.06% | -93.4% |
| Q1 2014 | $9,305,000 | +7.1% | 143,416 | -2.0% | 0.93% | +5.9% |
| Q4 2013 | $8,690,000 | +9.5% | 146,368 | -4.2% | 0.88% | +5.3% |
| Q3 2013 | $7,938,000 | +11.5% | 152,850 | +1.5% | 0.83% | +8.2% |
| Q2 2013 | $7,120,000 | – | 150,530 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
| Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
| Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
| Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
| Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
| Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
| Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
| ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
| CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |